Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient
2016 ◽
Vol 14
(5)
◽
pp. e525-e527
◽
2021 ◽
Vol Publish Ahead of Print
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 105
(1)
◽
pp. E665
Keyword(s):